Síguenos en Twitter     Síguenos en Facebook     Síguenos en YouTube     Siguenos en Linkedin     Correo Salutsantjoan     Gmail     Dropbox     Instagram     Google Drive     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon


My photo
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com




Friday, March 3, 2023

Single Troponin to Rule-out ACS

St. Emlyn`s JC - By Iain Beardsell - March 03, 2023
The Paper
The paper we will be discussing is from the European Heart Journal. As ever, we recommend that you read the whole paper yourself, and brilliantly the full text is free and available here
“Cyril Camaro et al. Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial, European Heart Journal, 2023”; https://doi.org/10.1093/eurheartj/ehad056
Summary and final thoughts
I think point-of-care testing has real potential to help us both risk stratify and also rule out certain conditions before the patient even gets to hospital. We need to be bold and consider where and when we can use these strategies and then support and educate the staff who are using them. The early data from the ARTICA trial suggests that this method may be safe and would be incredibly helpful in a significant large group of patients who currently need to be seen in hospital.